BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 194 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $472,632 | +0.6% | 66,756 | 0.0% | 0.09% | -2.1% |
| Q2 2023 | $469,962 | -16.8% | 66,756 | -1.5% | 0.10% | -18.8% |
| Q1 2023 | $565,085 | -27.0% | 67,756 | +0.5% | 0.12% | -28.7% |
| Q4 2022 | $773,637 | -8.9% | 67,390 | 0.0% | 0.16% | -23.0% |
| Q3 2022 | $849,000 | +19.6% | 67,390 | +0.5% | 0.21% | +27.5% |
| Q2 2022 | $710,000 | -60.0% | 67,088 | -38.6% | 0.17% | -52.3% |
| Q1 2022 | $1,775,000 | +17.4% | 109,188 | 0.0% | 0.35% | +23.7% |
| Q4 2021 | $1,512,000 | -3.6% | 109,188 | 0.0% | 0.28% | -12.1% |
| Q3 2021 | $1,569,000 | -11.2% | 109,188 | -2.2% | 0.32% | -11.0% |
| Q2 2021 | $1,766,000 | +42.8% | 111,678 | -8.2% | 0.36% | +35.6% |
| Q1 2021 | $1,237,000 | +57.8% | 121,678 | +15.7% | 0.27% | +37.6% |
| Q4 2020 | $784,000 | – | 105,178 | +15.4% | 0.19% | – |
| Q3 2020 | $0 | -100.0% | 91,178 | +10.3% | 0.00% | -100.0% |
| Q2 2020 | $394,000 | +126.4% | 82,678 | -5.1% | 0.12% | +88.7% |
| Q1 2020 | $174,000 | +58.2% | 87,078 | +172.1% | 0.06% | +93.8% |
| Q4 2019 | $110,000 | – | 32,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 3,846,154 | $44,153,847 | 52.00% |
| ORACLE INVESTMENT MANAGEMENT INC | 585,194 | $6,718,027 | 5.60% |
| Fairmount Funds Management LLC | 2,543,107 | $29,194,868 | 4.63% |
| Saturn V Capital Management LP | 340,163 | $3,751,030 | 3.11% |
| TANG CAPITAL MANAGEMENT LLC | 1,450,000 | $16,646,000 | 2.42% |
| Avoro Capital Advisors LLC | 9,050,000 | $103,894,000 | 1.55% |
| AlphaCentric Advisors LLC | 125,000 | $1,435,000 | 1.42% |
| Sarissa Capital Management LP | 980,288 | $11,253,706 | 1.34% |
| Ghost Tree Capital, LLC | 225,000 | $2,583,000 | 1.10% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 272,173 | $3,124,546 | 0.89% |